| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rezolute, Inc. (RZLT) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 1 sell. RZLT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 641.1K | $3.30M | - | |
| Other | 308.4K | $1.59M | - | |
| ? | 170.9K | $880.4K | - | |
| ? | 119.7K | $616.3K | - | |
| Other | 71.5K | $368.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2017 | Welch David F | Director | Buy | 10,000 | $0.93 | $9,263.00 | +200.0% | |
| Feb 9, 2015 | Elam Nevan C76 | Chief Executive Officer | Sell | 842,949 | $0.00 | - | -100% |